Sitaxentan
Top View
- Sitaxentan-Induced Hepatic Failure in Two Patients with Pulmonary Arterial Hypertension
- THELIN, INN-Sitaxentan Sodium
- THELIN (Sitaxentan Sodium) Encysive Pharmaceuticals Inc
- European Pharmaceuticals Pharmaceuticals Industry Update
- Supplementary File
- Known Bioactive Library: Selleck Bioactive 10Mm, 3.33Mm, 1.11Mm
- Anatomical Classification Guidelines V2018 EPHMRA ANATOMICAL
- (12) Patent Application Publication (10) Pub. No.: US 2015/0232461 A1 Nakai Et Al
- Lääkealan Turvallisuus- Ja Kehittämiskeskuksen Päätös
- Final Decisions and Reasons for Decisions by Delegates of the Secretary to the Department of Health
- Pulmonary Arterial Hypertension: Role of Ambrisentan
- Evaluation of Carcinogenicity Studies of Medicinal Products for Human Use Authorised Via the European Centralised Procedure
- Prescription Medications, Over-The-Counter Drugs, Herbs & Chemicals Associated with Tinnitus
- Informed Consent Form – Group A
- Pharmaceutical Compositions Comprising Prasugrel And
- TBC3711, an ETA Receptor Antagonist, Reduces Neonatal Hypoxia-Induced Pulmonary Hypertension in Piglets
- (12) Patent Application Publication (10) Pub. No.: US 2008/0066741 A1 Lemahieu Et Al
- Oregon Drug Use Review / Pharmacy & Therapeutics Committee